Coronary artery surgery results 2005 in Japan

Yukiyasu Sezai1, Yukihiko Orime, Saeki Tsukamoto

  • 11The Chairman of the board, Japanese Association for Coronary Artery Surgery, The Former President of Nihon University, Tokyo, Japan.

Insights

Coronary artery bypass grafting (CABG) in Japan achieved record-low mortality in 2005. The less-invasive off-pump CABG (OPCAB) procedure showed improved outcomes, becoming the preferred method for many patients.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Cardiac Surgery Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a critical intervention for coronary artery disease.
  • Annual surveys track surgical outcomes to identify trends and improvements.
  • The adoption of minimally invasive techniques is a key focus in modern cardiac surgery.

Purpose of the Study:

  • To report the national status and outcomes of coronary artery surgery in Japan for 2005.
  • To analyze trends in isolated CABG versus off-pump CABG (OPCAB).
  • To assess the impact of OPCAB on mortality rates and patient demographics.

Main Methods:

  • Analysis of a national registry of 12,207 coronary artery bypass grafting (CABG) cases performed in Japan from January 1 to December 31, 2005.
  • Comparison of operative mortality rates for isolated CABG and off-pump CABG (OPCAB).
  • Evaluation of patient demographics, including age and graft utilization.

Main Results:

  • Total CABG cases: 12,207; Isolated CABG cases: 9,827.
  • Operative mortality for isolated CABG: 1.91%; Initial elective CABG mortality: 0.89% (record low).
  • Off-pump CABG (OPCAB) accounted for 61.0% of cases (4,936), with improved mortality of 0.60%.
  • Elderly patients (≥70 years) comprised 46.5% of cases; arterial graft utilization was 70%.

Conclusions:

  • Japanese coronary artery surgery outcomes reached historic highs in 2005.
  • Off-pump CABG (OPCAB) is increasingly favored, demonstrating superior and improving mortality rates.
  • The aging patient population and high arterial graft use characterize contemporary CABG surgery.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...